Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer.

This network-based study presented hereby contributes to a better knowledge of the molecular underpinning of comorbidities associated with the kinases associated with the ALS disease and provides the potential therapeutic targets to disrupt the highly complex disease-causing network.